Skip to main navigation Skip to search Skip to main content

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

  • Mohammad Z. Ahmed
  • , Qamar Zia
  • , Anzarul Haque
  • , Ali S. Alqahtani
  • , Omar M. Almarfadi
  • , Saeed Banawas
  • , Mohammed S. Alqahtani
  • , Keshav L. Ameta
  • , Shafiul Haque
  • King Saud University
  • Majmaah University
  • Mody University of Science and Technology
  • Jazan University

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science